Get started
Work

Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry

Year: 2020
Type: article
Study design: Observational Study
Abstract: Elevated lipoprotein(a) [Lp(a)] is an independent risk factor for coronary heart disease, ischemic stroke, and calcific aortic valve stenosis. Mediated by the LPA gene, elevated Lp(a) is the most common inherited dyslipidemia affecting ∼20% of individuals.1 Lp(a) levels ≥50 mg/dL (≈125 nmol/L) correspond to the 80th percentile and represent the threshold at which its impact on atherosclerotic cardiovascular disease (ASCVD) becomes clinically meaningful.2 Given its genetic underpinnings, levels of Lp(a) are relatively stable throughout an individual’s lifetime and likely contribute to an accumulating risk starting from a young age.3 Current American Heart Association/American College of Cardiology guidelines view a family history of premature ASCVD as...
DOI: 10.1177/2047487320931296
Authors: Adam N Berman, David W Biery, Avinainder Singh, Wanda Y Wu, Sanjay Divakaran, Ersilia M DeFilippis, Jon Hainer, Michael J Blaha, Christopher Cannon, Donna M Polk, Jorge Plutzky, Pradeep Natarajan, Khurram Nasir, Marcelo F Di Carli, Deepak L Bhatt, Ron Blankstein
Institutions: Brigham and Women's Hospital, Harvard University, Yale University, Columbia University Irving Medical Center, Johns Hopkins University, Massachusetts General Hospital, Houston Methodist
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W3035328496
FWCI: 1.826
Cites: 16
Cited by: 19
Related to: 10